Transdermal fentanyl for cancer pain

  • Protocol
  • Intervention

Authors

  • Gina Hadley,

    Corresponding author
    1. University of Oxford, Pain Research and Nuffield Department of Clinical Neurosciences, Oxford, Oxfordshire, UK
    • Gina Hadley, Pain Research and Nuffield Department of Clinical Neurosciences, University of Oxford, Pain Research Unit, Churchill Hospital, Oxford, Oxfordshire, OX3 7LE, UK. glhadley@doctors.org.uk.

    Search for more papers by this author
  • Sheena Derry,

    1. University of Oxford, Pain Research and Nuffield Department of Clinical Neurosciences, Oxford, Oxfordshire, UK
    Search for more papers by this author
  • R Andrew Moore,

    1. University of Oxford, Pain Research and Nuffield Department of Clinical Neurosciences, Oxford, Oxfordshire, UK
    Search for more papers by this author
  • Philip J Wiffen

    1. University of Oxford, Pain Research and Nuffield Department of Clinical Neurosciences, Oxford, Oxfordshire, UK
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

  1. To determine the analgesic efficacy of transdermal fentanyl for relief of cancer pain.

  2. To assess the adverse effects associated with the clinical use of transdermal fentanyl for relief of cancer pain.

Ancillary